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Abstract
Background: The Glutathione S-transferases (GSTs) comprise a group of enzymes that are critical in the detoxification 
of carcinogens. In this study the effects of polymorphisms in these genes on the risk of developing oesophageal 
squamous cell carcinoma (OSCC) were evaluated in a hospital-based case-control study in two South African 
population groups. Genetic polymorphisms in GSTs were investigated in 245 patients and 288 controls samples by 
PCR-RFLP analysis.
Results: The GSTP1 341T variant was associated with significantly increased risk of developing OSCC as observed from 
the odds ratios for the GSTP1 341C/T and GSTP1 341T/T genotypes (OR = 4.98; 95%CI 3.05-8.11 and OR = 10.9; 95%CI 
2.43-49.1, respectively) when compared to the homozygous GSTP1 341C/C genotype. The risk for OSCC in the 
combined GSTP1 341C/T and T/T genotypes was higher in tobacco smokers (OR = 7.51, 95% CI 3.82-14.7), alcohol 
consumers (OR = 15.3, 95% CI 1.81-12.9) and those using wood or charcoal for cooking and heating (OR = 12.1, 95% CI 
3.26-49) when compared to those who did not smoke tobacco, or did not consume alcohol or user other forms of fuel 
for cooking and heating. Despite the close proximity of the two GSTP1 SNPs (313A>G and 341C>T), they were not in 
linkage disequilibrium in these two population groups (D':1.0, LOD: 0.52, r2: 0.225). The GSTP1 313A/G polymorphism 
on the other hand, did not display any association with OSSC. The homozygous GSTT1*0 genotype was associated with 
increased risk of OSCC (OR = 1.71, 95%CI 1.18-2.46) while the homozygous GSTM1*0 genotype was associated with 
significantly decreased risk of OSCC in the Mixed Ancestry subjects (OR= 0.39, 95%CI 0.25-0.62).
Conclusions: This study shows that the risk of developing OSCC in the South African population can be partly 
explained by genetic polymorphisms in GST coding genes and their interaction with environmental factors such as 
tobacco smoke and alcohol consumption.
Background
Oesophageal squamous cell carcinoma (OSCC) is the
second most common cancer among African males in
South Africa [1,2]. Although very little is known about
the aetiology of OSCC in this population, several risk fac-
tors such as tobacco smoking, alcohol consumption and
the prolonged use of wood or charcoal as sources of fuel
for cooking and heating (resulting in excessive smoke
inhalation), have generally been implicated [3,4]. Somatic
mutations in the human pro-collagen genes [5], genetic
polymorphisms in the androgen receptor gene [6], or
genes coding for phase I and phase II detoxification
enzymes [7-9], exposure to aflatoxin-, and fumonisin-
contaminated maize, human papilloma virus (HPV)
infection [10] and a habit of regular forced vomiting have
all been proposed as major risk factors for OSCC among
South Africans. Recent data imply that the environmental
risk factors may be modified by polymorphisms in the
carcinogen metabolizing genes i.e. gene-environment
interactions [7].
The glutathione S-transferase (GST) family of enzymes
play an important role in the detoxification of carcino-
gens by catalyzing the conjugation of glutathione (GSH)
to electrophilic compounds [11-14]. Multiple tissue-spe-
cific GST isoforms accommodate a diverse range of sub-
strates, thus conferring tissue specificity in the handling
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of certain carcinogens. Although there is evidence for the
role of genetic polymorphisms in the alpha (A), mu (M),
theta (T) and pi (P) GST gene families in a number of
cancers [15-19], the current study investigated the role of
the latter three in OSCC among South Africans because
of their biological relevance in the metabolism of known
carcinogens, allelic frequency and implications in previ-
ous epidemiological studies on cancer [15-19].
GSTM1 is principally expressed in the liver, with low
levels in extra hepatic tissues. Genetic polymorphisms in
the gene are due to either gene deletion (giving rise to
GSTM1*0) or a single nucleotide change 534 C/G (caus-
ing the replacement of lysine 172 by aspartic acid) result-
ing in two alleles GSTM1*A and GSTM1*B, whose gene
products do not show any differences in activity [13,14].
The GSTM1*0 occurs at different frequencies in different
populations: 19%-33% in Africans [15-17], 30%-52%
among Caucasians [18,19] and 55% among Asians [20].
GSTT1 on the other hand, is expressed at high levels in
extra hepatic tissues, including the kidney, liver and the
gastrointestinal tract, suggesting an important role in the
protection against carcinogens and other xenobiotics in
these tissues [13,21,22]. Two GSTT1 variants have been
identified, one is an entire gene deletion (referred to as
GSTT1*0) [23] and the second is a single base change,
310 A/T (referred to as GSTT1*B) which is associated
with abolished GSTT1 activity [24]. There is a clear eth-
nic variation in the distribution of the homozygous
GSTT1 null genotype occurring in 10%-26% Africans and
Caucasians [15-18] and 55%-75% in Koreans, Japanese
and Chinese [20,25,26].
GSTP1 is the major GST expressed in extra hepatic tis-
sues such as the lungs and the oesophagus with very little
expression in the liver [13,21,22] and has been shown to
be over expressed in several malignant tissues compared
to their matched normal tissues [27]. Two single nucle-
otide polymorphisms (SNPs) in GSTP1 resulting in
amino acid substitutions that affect enzyme activity func-
tion are rs1695 (formerly rs947894 which is due to an
A313G substitution resulting in an Ile105Val amino acid
change) and rs1138272 (formerly rs1799811 which is due
to a C341T substitution resulting in an Ala114Val amino
acid change) [28-30]. The GSTP1 313G variant has been
widely studied and occurs at frequencies of 14%-20%
among Black Africans [15,16], 28%-32% among Cauca-
sians [31] and 14-18% among Asians [29,32]. Very few
studies have investigated the role of the GSTP1 341T
variant in the development of OSCC. We investigated the
role of the GSTM1, T1 and P1 polymorphisms in OSCC
because of the conflicting reports on their role in gastric,
breast and lung cancers [33-36]. Our data suggest that the
GSTP1 341T variant significantly predisposes individuals
to OSCC.
Results
Distribution of GSTP1 alleles and genotypes
The distribution of the GSTP1 313 A/G polymorphism
was not significantly different between patients and con-
trols among either the Black or the Mixed Ancestry
groups. The GSTP1 313G variant occurred with a fre-
quency of 39% in patients vs. 37% in controls in the Black
subjects and 38% in patients vs. 41% in controls in the
Mixed Ancestry subjects. In contrast, the distribution of
the  GSTP1 341C/T polymorphism differed between
patients and controls with the GSTP1 341T variant
occurring at frequencies of 22% in patients vs. 7% in con-
trols in the Black population and 19% in patients vs. 3% in
controls in those of Mixed Ancestry (Table 1). In both the
Black and the Mixed Ancestry subjects, the GSTP1 341T
variant was associated with significantly increased risk of
OSCC as observed from the heterozygous GSTP1 341C/
T and homozygous GSTP1 341T/T genotypes which were
associated with increased risk for developing OSCC
among both the Black African and Mixed Ancestry sub-
jects (OR = 4.98; 95%CI 3.05-8.11 and OR = 10.9; 95%CI
2.43-49.1, respectively, for each genotype). Odds ratios
for each racial group separately are provided in additional
file 1.
Of the 116 subjects who were either homo- or
heterozygous for the GSTP1 341C/T polymorphism 76%
(n = 88) were patients while only 24% (n = 28) were con-
trols. It is important to note that this report is one of very
few studies on the GSTP1 341C/T polymorphism in
OSCC since most published studies focus on the GSTP1
313A/G polymorphism. Using linkage format in Haplo-
View to calculate linkage between GSTP1 313A/G and
GSTP1 341C/T SNPs the following parameters were
observed, D':1.0, LOD: 0.52 and r2: 0.225. The observed
haplotypes were AT (0.555), CG (0.202), GT (0.159) and
AC (0.084). Analyses of the stratification between GSTP1
and tobacco smoking habits, alcohol consumption and
combustion of charcoal or wood as fuel, the GSTP1
341C/T+341T/T combined genotypes were associated
with a higher risk for OSCC among tobacco smokers (OR
= 7.51, 95%CI 3.82-14.7), alcohol consumers (OR = 15.3,
95%CI 1.81-12.9) and among users of charcoal or wood
for fuel (OR = 12.1, 95% CI 3.26-49) when compared to
non-smokers (OR = 5.31, 95% CI 2.58-27.6), non-alcohol
consumers (OR = 10.9, 95% CI 4.09-28.9) and users of
other forms of fuel for cooking and heating (OR = 4.93,
95% CI 2.47-9.84) (Table 2). When measures of biological
interaction were calculated the GSTP1 341C/T+341T/T
combined genotype was associated with high relative risk
for OSCC only among users of wood/charcoal (RR =
29.9) and tobacco smokers (RR = 4.28) while GSTM1*0/
*0 genotype interacting with smoking was surprisingly
associated with reduced relative risk (RR = 0.364) (Table
3 and Additional file 2). Additional file 2 shows the rela-Li et al. BMC Genetics 2010, 11:47
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tive risk with contributions from GSTP1 341C/T+341T/
T combined genotype and exposure to either use of
wood/charcoal as fuel for heating and cooking and
GSTM1*0/*0 interacting with tobacco smoking, respec-
tively In all the above statistical analyses on the genotype
distribution and interaction variables the parameters
were adjusted for each other (tobacco smoking, alcohol
consumption, race, age, gender and use of wood or char-
coal). Interestingly, all wood or charcoal users with the
GSTP1 341T/T genotype (results not shown) were
patients and of the 15 subjects who had the GSTP1 341T/
T genotype, 14 (93%) were smokers of whom, 13 were
patients.
GSTM1 and T1 frequency distribution
Using logistic regression analysis, the effects of homozy-
gous GSTM1 deletion (rs4025935) and GSTT1 gene dele-
tion (rs71748309) were calculated after adjusting for sex
(our previous paper had shown a 2-fold risk among men),
r a c e  ( d u e  t o  t h e  o bse rv ed  d i ff e r e n c e s  i n  t h e  a l l e l e  f r e -
quencies in the Black and Mixed Ancestry subjects),
tobacco smoking, alcohol consumption and age. The
homozygous GSTT1*0 genotype was associated with sig-
nificantly increased risk of OSCC (OR = 1.71, 95% CI
1.18-2.46) while the homozygous GSTM1*0 genotype was
associated with significantly decreased risk of OSCC (OR
= 0.39, 95% CI 0.25-0.62). These results support our ear-
lier observations with the CYP3A5 and SULT1A1 gene
polymorphisms [7,8].
Combinations of GSTM1, T1 and P1 genotypes
The expression of human GSTs shows unique tissue spec-
ificity; thus, tissues that express a variety of GSTs are
probably more effective in detoxifying a wide range of
carcinogens. We evaluated the effects of having certain
GST genotype combinations on the risk for OSCC and
used a logistic model to take into account the contribu-
tion of other confounders (Table 4). All the genotype
Table 1: The distribution of the GST genotypes in Black and Mixed Ancestry in South Africans
Genotypes Black African subjects Mixed Ancestry subjects Analysis of subjects combined
Patients
N (%)
Controls
N (%)
Patients
N (%)
Controls
N (%)
OR1 (95%CI) p-value OR2 (95%CI) p-value
GSTT1a
*1 57 (40) 109 (59) 68 (68) 69 (73) 1.00 1.00
*0 (rs71748309) 84 (60) 77 (41) 29 (29) 25 (27) 1.55 (1.09-2.21) 0.014 1.71 (1.18-2.46) 0.004
GSTP1 313 A/G (Ile105Val) (rs1695)
313A/A 56 (40) 76 (41) 34 (34) 30 (32) 1.00
313A/G 59 (42) 83 (45) 52 (52) 51 (54) 0.96 (0.66-1.40) 0.846 1.01 (0.68-1.48) 0.973
313G/G 26 (18) 27 (14) 11 (11) 13 (14) 1.08 (0.64-1.82) 0.786 1.21 (0.71-2.07) 0.490
Test for deviation from Hardy-Weinberg Equilibrium
χ2 2.139 0.360 1.874 1.407
p 0.144 0.549 0.177 0.236
313A freq 0.61+0.03 0.63+0.02 0.62+0.03 0.59+0.03
313G freq 0.39+0.03 0.37+0.02 0.38+0.03 0.41+0.03
GSTP1 341 C/T (Ala114Val) (rs1138272)
341C/C 85 (60) 163 (88) 65 (65) 89 (95) 1.00 1.00
341C/T 49 (35) 21 (11) 27 (27) 5 (5) 4.98 (3.05-8.11) 0.001 5.05 (3.06-8.32) 0.001
341T/T 7 (5) 2 (1) 5 (5) 0 (0) 10.9 (2.43-49.1) 0.002 9.58 (2.08-44.0) 0.004
Test for deviation from Hardy-Weinberg Equilibrium
χ2 0 1.397 0.876 0.137
p 0.986 0.237 0.349 0.712
341C freq 0.78+0.02 0.93+0.01 0.81+0.03 0.97+0.01
341T freq 0.22+0.02 0.07+0.01 0.19+0.03 0.03+0.01
OR1, odds ratio not adjusted for confounders; OR2, odds ratio adjusted for the following confounding variables, age, sex, race, tobacco smoking, 
alcohol consumption and use of wood or charcoal; . a *1 signifies carrier of gene (either homozygous or heterozygous carrier), *0 signifies 
homozygous gene deletionLi et al. BMC Genetics 2010, 11:47
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Table 2: Interactions between GST genotypes, alcohol consumption, tobacco smoking and fuel source among 
oesophageal cancer patients and controls
Genotypes Patients N(%) Controls N(%) OR (95%CI) p-value Patients N(%) Controls N (%) OR (95%CI) p-value
Tobacco smokersa Non smokersa
GSTT1*1 100 (56) 112 (61) 1.00 27 (43) 66 (69) 1.00
GSTT1*0 77 (44) 73 (39) 1.01 (0.62-1.66) 0.951 36 (57) 29 (31) 2.92(1.04-8.16) 0.042
GSTM1*1 151 (85) 125 (68) 1.00 55 (87) 75 (79 1.00
GSTM1*0 125 (15) 60 (32) 0.30 (0.16-0.56) 0.001 8 (13) 20 (21) 0.46 (0.12-1.81) 0.269
GSTP1 313A/A 71 (40) 77 (42) 1.00 21 (33) 30 (32) 1.00
GSTP1 313 A/G 78 (44) 86 (46) 0.96 (0.58-1.61) 0.898 33 (52) 48 (50) 0.53 (0.18-1.51) 0.233
GSTP1 313G/G 28 (16) 22 (12) 1.54 (0.74-3.21) 0.250 9 (14) 17 (18) 0.44 (0.10-1.93) 0.278
GSTP1 341 C/C 106 (60) 166 (90) 1.00 44 (70) 86 (91) 1.00
GSTP1-341C/T + GSTP1-
341T/T
71 (40) 19 (10) 7.51 (3.82-14.7) 0.001 19 (30) 9 (9) 5.31 (2.58-27.6) 0.001
Alcohol consumersb Non consumersb
GSTT1*1 89 (54) 101 (60) 1.00 38 (51) 77 (68) 1.00
GSTT1*0 76 (46) 66 (40) 1.03 (0.60-1.77) 0.911 37 (49) 36 (32) 1.66 (0.77-3.59) 0.197
GSTM1*1 143 (87) 123 (74) 1.00 63 (84) 77 (68) 1.00
GSTM1*0 22 (13) 44 (26) 0.33 (0.16-0.66) 0.002 12 (16) 36 (32) 0.27 (0.10-0.74) 0.011
GSTP1 313A/A 63 (38) 74 (44) 1.00 29 (39) 33 (29) 1.00
GSTP1 313 A/G 80 (48) 75 (45) 1.22 (0.70-2.13) 0.474 31 (41) 58 (52) 0.41 (0.17-0.96) 0.039
GSTP1 313G/G 22 (13) 18 (11) 1.69 (0.72-3.95) 0.226 15 (20) 22 (19) 0.64 (0.24-1.76) 0.394
GSTP1 341 C/C 105 (64) 148 (89) 1.00 45 (60) 104 (92) 1.00
GSTP1-341C/T + GSTP1-
341T/T
60 (36) 19 (11) 15.3 (1.81-12.9) 0.012 30 (40) 9 (8) 10.9 (4.09-28.9) 0.001
Wood or charcoal usersc Non usersc
GSTT1*1 54 (61) 25(58) 1.00 52 (60) 153 (65) 1.00
GSTT1*0 34 (39) 18 (42) 0.77 (0.35-1.68) 0.510 35 (40) 84 (35) 1.67 (0.94-2.93) 0.080
GSTM1*1 72 (82) 27 (63) 1.00 77 (89) 173 (73) 1.00
GSTM1*0 16 (18) 16 (37) 0.41 (0.17-0.96) 0.041 10 (11) 64 (27) 0.26 (0.12-0.56) 0.001
GSTP1 313A/A 38 (43) 17 (40) 1.00 34 (39) 90 (38) 1.00
GSTP1 313 A/G 34 (39) 23 (53) 0.71 (0.30-1.69) 0.441 41 (47) 110 (46) 0.97 (0.55-1.73) 0.922
GSTP1 313G/G 16 (18) 3 (7) 3.28 (0.79-13.7) 0.103 12 (14) 37 (16) 1.11 (0.48-2.53) 0.809
GSTP1 341 C/C 42 (48) 40 (93) 1.00 57 (66) 212 (89) 1.00
GSTP1-341C/T + GSTP1-
341T/T
46 (52) 3 (7) 12.1 (3.26-49.0) 0.001 30 (34) 25 (11) 4.93 (2.47-9.84) 0.001
*1 signifies carrier of gene, *0 signifies homozygous gene deletion. Odds ratios adjusted for aalcohol consumption, race, sex, age, wood or 
charcoal use; btobacco smoking , race, sex, age, wood or charcoal use; calcohol consumption, race, sex, age, tobacco smoking
combinations were analysed after adjusting for the cova-
riates which had shown an effect on oesophageal cancer
when we applied the maximum likelihood probit estima-
tion (Probit estimates: number of observations = 535, LR
Chi2(10) = 257.64, P > Chi2= 0.0001). Having the GSTP1
341C/T+341 T/T genotype in combination with the
homozygous  GSTT1*0  genotype was associated with a
higher risk of OSCC (OR = 14.9, 95% CI 5.64-39.4) when
compared to the GSTP1 341C/T+341T/T in combination
with the GSTT1*1 genotype (OR = 3.76, 95% CI 1.82-
7.77) (Table 4). Furthermore, all the subjects with a com-
bination of the homozygous GSTP1 341T/T genotype
and the GSTT1*0 genotype (n = 3) were patients (data not
shown). This combination represents severely reduced
detoxification capacity due to deletion of GSTT1 and the
selective activity of the GSTP1 341T variant protein, thus
confirming the important role of these GSTs in detoxifi-
cation. Interpretation of significance was corrected usingLi et al. BMC Genetics 2010, 11:47
http://www.biomedcentral.com/1471-2156/11/47
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the Bonferroni correction such that significance in the
interaction models in Table 4 was only noted when the P
value was < 0.025.
Interestingly, of the 15 subjects homozygous for the
GSTP1 341T/T genotype, 80% (n = 12) had the GSTT1
wild type genotype (data not shown). Furthermore, none
of the subjects had a combination of the GSTM1*0 geno-
type + homozygous GSTP1 341T/T genotype; Thus, all
the subjects (n = 15) with the homozygous GSTP1 341T/
T genotype were GSTM1 positive and 87% of them (n =
13) were OSCC patients, possibly pointing to compensa-
tion between genes such that, in the absence of GSTM1
(the case of deletion) there is most likely to be another
normally functioning GST gene whose product partici-
pates in the same metabolic pathway (in this case GSTP1
341C/C).
Discussion
The disproportionate geographical distribution of OSCC
can be attributed to differences in environmental expo-
sures while the variability observed amongst residents of
the same locality can be attributed mainly to differences
in genetic predisposition and to host defence mecha-
nisms. Most environmental carcinogens require prior
metabolic activation in order to elicit their effects but
many of the enzymes involved in carcinogen metabolism
exhibit genetic polymorphisms resulting in variability in
both their level of expression [37] and activity [38,39].
This study investigated the role of such polymorphic vari-
ants in the glutathione S-transferase genes because of
their involvement in the detoxification of many carcino-
gens as one of the major phase II enzymes. Although
multiple forms of GSTs can accommodate diverse sub-
strates, the distribution of the GST isoforms varies
between different tissues, suggesting potential differences
in the manner in which these tissues are detoxified
[13,21].
The observation that tobacco smokers, alcohol con-
sumers or those using wood or charcoal for cooking and
heating carrying the GSTP1 341T variant in either the
heterozygous or homozygous form had a higher risk of
developing OSCC might be due to decreased detoxifica-
tion of carcinogens as a result of decreased activity of the
GSTP1 variant or changed substrate specificity
[7,28,30,31]. The higher incidence of OSCC among
tobacco smokers who either had the heterozygous GSTP1
341C/T genotype or homozygous GSTP1 341T/T geno-
type clearly indicates a gene-environment interaction.
This is the first study showing an association between
genetic polymorphism in GSTP1 and OSCC in the South
African population.
Of all the GST enzymes, GSTP1 has the highest specific
activity towards benzo (α) pyrene diol epoxide and benzo
(α) pyrene-7ß, α hydrodiol-9 α,10 α-epoxide (BPDE), the
Table 3: Calculating measures of biological interaction between genotypes and environmental exposures
Dichotomous risk 
factors
RR 95% CI RERI AP S
Risk 1a(Genotypes) Risk 2 lower upper
GSTT1*0/*0 alcohol 2.158 1.175 3.965 -0.322 -0.149 0.783
GSTT1*0/*0 smoking 1.771 0.958 3.274 -1.559 -0.880 0.331
GSTT1*0/*0 wood/charcoal 2.738 1.443 5.198 0.213 0.078 1.140
GSTM1*0/*0 alcohol 0.399 0.165 0.760 0.058 0.145 0.912
GSTM1*0/*0 wood/charcoal 1.075 0.508 2.276 -1.641 -1.527 0.044
GSTM1*0/*0 smoking 0.364 0.190 0.699 -0.148 -0.407 1.304
GSTP1 313 A/G +G/G alcohol 0.922 0.488 1.743 0.597 0.647 0.115
GSTP1 313A/G +G/G smoking 0.779 0.390 1.553 0.113 0.145 0.663
GSTP1 313A/G +G/G wood/charcoal 1.738 0.978 3.087 0.185 0.107 1.335
GSTP1 341C/T+T/T alcohol 6.321 3.054 13.09 -0.514 -0.081 0.912
GSTP1 341C/T+T/T smoking 4.284 2.158 8.507 1.032 0.241 1.458
GSTP1 341C/T+T/T wood/charcoal 29.87 8.968 99.49 27.38 0.917 19.40
aThe references for the interaction exposures were; GSTM1*1 + non-exposure, GSTT1*1 + non-exposure, GSTP1 313 A/A + non-exposure, GSTP1 
341 C/C + non-exposure. Where non exposure refers to any of the following; non-smoker, non-alcohol consumer, and not exposed to use of 
wood/charcoal. The interaction model used could only factor in two dichotomous risk factors. Thus the following genotype combinations were 
used; GSTM1 (GSTM1*1/*1 vs. GSTM1*0/*0); GSTT1 (GSTT1*1/*1 vs. GSTT1*0/*0); GSTP105 (A/A vs. A/G+GG); GSTTP114 (C/C vs. C/T+T/T). For each 
interaction, four disjoint categories were created. For example, in the case of smoking and GSTP114 (non-smoker and C/C, non-smoker and C/
T+TT, smoker and C/C, smoker and C/T+T/T). RR= relative risk; RERI = the relative excess risk due to interaction; AP = the attributable risk due to 
interaction; S = the synergy index.Li et al. BMC Genetics 2010, 11:47
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major metabolites of benzo (α) pyrene [30]. Benzo (α)
pyrene and its metabolites are some of the major compo-
nents of cigarette smoke [40] and are also detected in
wood or charcoal combustion under conditions of limited
oxygen supply. GSTP1 is predominantly expressed in
extra hepatic tissues including the oesophagus and is
therefore likely to play a major role in the detoxification
of carcinogens that are activated within these tissues
[13,21,22].
The GSTM1*0 genotype on the other hand, was gener-
ally associated with decreased risk of OSCC. Our obser-
vation for GSTT1*0 and GSTM1*0 is in agreement with
other findings in the Caucasian populations [41] and con-
trary to the report by Anantharaman et al. [42] who
o b s e r v e d  a n  i n v e r s e  c o r r e l a t i o n ,  i . e .  r e d u c e d  r i s k  o f
OSCC among Indian carriers of the GSTT1*0 genotype
and increased risk among GSTM1*0 carriers. The above
differences could be due to the type of environmental
exposures, quantity of exposure, method of exposure and
the tissue distribution of the GST enzymes [13,22]. The
widely studied GSTP1 polymorphism, GSTP1 313A/G,
was not associated with any risk for OSCC in any of the
population groups in our study. The observed risks asso-
ciated with the GSTP1 313A/G in other studies could be
due to linkage disequilibrium between this polymor-
phism and the GSTP1 341C/T polymorphism, a phenom-
enon which was not manifested in the South African
population when one considers the linkage parameters
calculated using HaploView (D': 1.0, LOD:0.52, r2: 0.225).
The variation in the impact of GSTM1, GSTT1 and
GSTP1 in oesophageal cancer susceptibility could be due
to their differences in organ localization and metabolic
functions [11,13,21,22]. The differences observed across
different ethnic groups in different geographical areas
could be due to differences in major exposure variables
and environmental interactions. The above is even more
plausible in the case of GSTP1 in which the allelic vari-
ants have been shown to differentially and preferentially
metabolize bulky substrates compared to the wild type
allele [30,31]. It should be noted that our results may not
be able to satisfy the power requirements for gene fre-
quencies that are less than 15%.
Conclusions
We have shown that the risk of developing OSCC in the
South Africa population can be partly explained by inter-
actions between genetic polymorphisms in the GST
genes and environmental factors such as tobacco smok-
ing and alcohol consumption. The GSTP1 341 C/T poly-
morphism was associated with the higher risks for OSCC
among subjects exposed to potential sources of carcino-
gens.
Table 4: Comparison of the risk of SCC of the oesophagus associated with different GST genotypes
Genotypes Patients N(%) Controls N(%) OR (95%CI) p-value  Patients N(%) Controls N(%) OR (95%CI) p-value 
GSTM1*0 GSTM1*1
GSTM1*1 98 (87) 65 (64) 1.00 108 (85) 135 (76) 1.00
GSTM1*0 15 (13) 37 (36) 0.27 (0.12-0.62) 0.002 19 (15) 43 (24) 0.36 (0.17-0.76) 0.008
GSTP1 313A/A 49 (43) 38 (37) 1.00 43 (34) 69 (39) 1.00
GSTP1 313 A/G 49 (44) 50 (49) 0.51 (0.25-1.05) 0.069 62 (49) 84 (47) 1.28 (0.69-3.37) 0.434
GSTP1 313G/G 15 (13) 14 (14) 0.42 (0.13-1.33) 0.139 22 (17) 25 (14) 2.36 (1.04-5.37) 0.041
GSTP1 341 C/C 70 (62) 94 (92) 1.00 80 (63) 158 (89) 1.00
GSTP1-341C/T + 
GSTP1-341T/T
43 (38) 8 (8) 14.9 (5.64-39.4) 0.001 47 (37) 20 (11) 3.76 (1.82-7.77) 0.001
GSTM1*0 GSTM1*1
GSTT1*1 19 (56) 43 (54) 1.00 108 (52) 135 (68) 1.00
GSTT1*0 15 (44) 37 (46) 0.73 (0.25-2.10) 0.559 98 (48) 65 (32) 1.55 (093-2.58) 0.093
GSTP1 313A/A 13 (38) 32 (40) 1.00 79 (38) 75 (37) 1.00
GSTP1 313 A/G 15 (44) 39 (49) 1.63 (0.52-5.12) 0.40 96 (47) 95 (48) 0.80 (0.47-1.36) 0.417
GSTP1 313G/G 6 (18) 9 (11) 2.78 (0.59-13.0) 0.193 31 (15) 30 (15) 1.04 (0.50-2.19) 0.914
GSTP1 341 C/C 22 (65) 73 (91) 1.00 128 (62) 179 (90) 1.00
GSTP1-341C/T + 
GSTP1-341T/T
12 (35) 7 (9) 6.06 (1.79-20.5) 0.004 78 (38) 21 (10) 6.31 (3.26-12.2) 0.001
OR, odds ratios adjusted for age, sex, race, tobacco smoking, alcohol consumption and use of charcoal or wood for cooking. *1 signifies carrier of 
gene, *0 signifies homozygous gene deletion.Li et al. BMC Genetics 2010, 11:47
http://www.biomedcentral.com/1471-2156/11/47
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Methods
Study subjects
The general design of the study has been as previously
described [7-9]. Briefly, all the patients (n = 245) were
diagnosed with histologically confirmed OSCC at Groote
Schuur Hospital, Cape Town, South Africa. Controls (n =
288) were age, sex, and geographically-matched individu-
als to the patients but with no obvious sign of disease.
Controls with prior history of cancer were excluded. The
patients and controls were recruited between 1997 and
2003 and were the same as those reported in earlier stud-
ies [7-9]. The Black subjects were Xhosa-speaking South
Africans who originally came from either the Eastern
Cape or the Western Cape. The Mixed Ancestry (com-
monly referred to as “coloured”) subjects are a result of
intermarriages between races including Black Africans,
Western Europeans, the Khoisan, Indonesians, and
Malaysians who settled in the Cape from the middle of
the 17th  century. Written or informed consent was
obtained before subjects were enrolled into the study. A
questionnaire gathering details on demographics (age,
sex, and race), smoking habits, alcohol consumption and
family history of cancer was completed on all subjects by
a trained interviewer. The classification of tobacco smok-
ers and alcohol consumers was according to Dandara et
al. [7]. Blood was collected from all participating subjects
by a trained phlebotomist and processed for DNA isola-
tion. This study was approved by the University of Cape
Town, Human Ethics Research Committee.
Sample size was calculated using an online software by
Daniel Soper http://www.danielsoper.com/statcalc/
calc01.aspx, using alpha 0.05, six possible predictors of
oesophageal cancer (race, tobacco smoking, alcohol con-
sumption, race/ethnicity, age and use of charcoal or wood
as fuel for cooking and heating), an anticipated minimum
allele frequency of 0.15 for each of the gene variants or
polymorphisms and desired 90% power. This meant that
we required a minimum of 123 samples.
GSTM1 and GSTT1 genotyping
Genotyping of the GSTT1 and GSTM1 alleles was per-
formed by multiplex PCR using minor modifications of
the method of Arand et al. [43] using human serum albu-
min (HSA) as an internal control. The primer pairs used
in the amplification of GSTT1, GSTM1 and HSA were,
5'-TTC CTT ACT GGT CCT CAC ATC TC-3'/5'-TCA
CCG GAT CAT GGC CAG CA-3', 5'-GAA CTC CCT
GAA AAG CTA AAG C-3'/5'-GTT GGG CTC AAA TAT
ACG GTG G-3'and 5'-GCC CTC TGC TAA CAA GTC
CTA C -3'/5'-GCC CTA AAA AGA AAA TCC CCA
ATC-3', respectively. PCR amplification generated 480
bp, 219 bp, and 350 bp fragments for GSTT1, GSTM1
and HSA, respectively. Each multiplex PCR reaction con-
sisted of 100 ng genomic DNA, 1×PCR buffer containing
1.5 mM MgCl2, 0.2 mM dNTP mixture, 0.2 μM of
GSTM1 primers, 0.3 μM of GSTT1 and HSA primers and
1 U Taq DNA polymerase (Biotaq™) in a final volume of
50 μl. The PCR consisted of an initial denaturation step at
94°C for 5 minutes, followed by 35 cycles of denaturation
at 94°C for 1 minute, annealing at 62°C for 1 minute, elon-
gation at 72°C for 1 minute and a final extension step at
72°C for 5 minutes. The amplified products were visual-
ised by electrophoresis in ethidium-bromide-stained 2%
agarose gel. Gene deletion was assumed as the absence of
either or both of the GSTM1 or GSTT1 fragments in the
presence of the HSA fragment.
Detection of the GSTP1 single nucleotide polymorphisms, 
313 A/G and 341C/T
The genotyping of the GSTP1 gene for the detection of
the single nucleotide changes, 313A/G (rs1695, GSTP1
Ile105Val) and 341C/T (rs1138272, Ala114Val) was done
according to the method of Tan et al. [44]. The primer
pairs used in the PCR amplification were, 5'-ACG CAC
ATC CTC TTC CCC TC-3'/5'-TAC TTG GCT GGT
TGA TGT CC-3'and 5'-CAA GGA TGG ACA GGC AGA
ATG G -3'/5'-ATG GCT CAC ACC TGT GTC CAT C-3',
respectively. Each PCR reaction contained 100 ng
genomic DNA, 1×PCR buffer containing 1.5 mM MgCl2,
0.2 mM dNTP mixture, 0.2 μM of both primer set and 1
U Taq  DNA polymerase (Takara or Invitrogen) in final
volume of 50 μl. The PCR conditions for both reactions
were as follows, denaturation step at 95°C for 3 minutes,
followed by 30 cycles of denaturation at 95°C for 30 sec-
onds, annealing at 57°C/63°C for 30 seconds, elongation
at 72°C for 30 seconds and a final extension at 72°C for 7
minutes. The PCR products were digested using Bsm AI
(wildtype = 440 bp, mutant = 212 bp + 228 bp) or Aci I
(wild type = 172 bp + 195 bp, mutant = 367 bp) for the
detection of the 313A/G or 341C/T base changes, respec-
tively.
Statistical analysis
The patient and control DNA samples were genotyped
randomly without the researcher knowing whether they
were working on patient or control DNA. STATA was
used for the multivariate analysis and logistic regression
in order to compare the distribution of the different vari-
ables between patients and controls, using odds ratios
(OR) and the 95% confidence intervals (95%CI). Interac-
tions between tobacco smoking, alcohol consumption,
use of wood and GST genotypes were analyzed. The odds
ratios were adjusted for sex and age. A p-value of <0.05
was considered statistically significant. There was no dif-
ference in statistical significance after Bonferroni Correc-
tion for multiple comparisons (i.e. reducing significance
level to p= 0.017). Tests for deviation from Hardy-Wein-
berg Equilibrium were calculated using online programLi et al. BMC Genetics 2010, 11:47
http://www.biomedcentral.com/1471-2156/11/47
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software on: http://ihg.gsf.de (under the link; Genotyp-
ing). This software is provided by the Institute of Human
Genetics (Technical University Munich +Helmholtz Cen-
ter Munich) German Research Center for Environmental
Health. There was no deviation from Hardy- Weinberg
among controls in the genotyping for the two GSTP1 sin-
gle nucleotide polymorphisms.
Calculation of measures of biological interaction
Measures of biological interaction were calculated from
values obtained from logistic regression and covariance
analysis using STATA according to Andersson et al. [45]
to produce the output necessary for assessment of biolog-
ical interaction using a model found on: http://www.epi-
net.se. The model calculates the following measures of
biological interaction; RR, relative risk; RERI, the relative
excess risk due to interaction; AP, the attributable propor-
tion due to interaction; S, the synegy index (see Table 3).
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